The Use of {beta}L/{beta}LIs for ESBL Infections: Defining the Right Patient Population [PublishAheadOfPrint]

In a multicenter, multinational observational study including neutropenic patients with extended-spectrum β-lactamase-producing bloodstream infections, Gudiol and colleagues demonstrate that β-lactam/β-lactamase inhibitors are effective treatment options. A review of this study, however, reminds us that some lingering questions remain for specific high-risk subgroups.

http://ift.tt/2rYI6nH